drugset
drugset / Trial / NCT02989519

Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor

NCT02989519 ↗

Phase 3 Completed 231 enrolled Sanpasitthiprasong Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine efficacy of vaginal and oral progesterone after tocolytic therapy in threatened preterm labor

Timeline

Start
2015-08
Primary completion
2017-01-05
Completion
2017-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg Oral
Subject Progesterone Other / unclassified 200 mg Intravenous

Indications

No indication recorded.